1 Trivalent Flu Vaccine Market Overview 1.1 Trivalent Flu Vaccine Product Overview 1.2 Trivalent Flu Vaccine Market Segment by Type 1.2.1 Intramuscular Injection 1.2.2 Nasal Spray 1.2.3 Intradermal Shot 1.3 Global Trivalent Flu Vaccine Market Size by Type (2015-2026) 1.3.1 Global Trivalent Flu Vaccine Market Size Overview by Type (2015-2026) 1.3.2 Global Trivalent Flu Vaccine Historic Market Size Review by Type (2015-2020) 1.3.2.1 Global Trivalent Flu Vaccine Sales Market Share Breakdown by Type (2015-2026) 1.3.2.2 Global Trivalent Flu Vaccine Revenue Market Share Breakdown by Type (2015-2026) 1.3.2.3 Global Trivalent Flu Vaccine Average Selling Price (ASP) by Type (2015-2026) 1.3.3 Global Trivalent Flu Vaccine Market Size Forecast by Type (2021-2026) 1.3.3.1 Global Trivalent Flu Vaccine Sales Market Share Breakdown by Application (2021-2026) 1.3.3.2 Global Trivalent Flu Vaccine Revenue Market Share Breakdown by Application (2021-2026) 1.3.3.3 Global Trivalent Flu Vaccine Average Selling Price (ASP) by Application (2021-2026) 1.4 Key Regions Market Size Segment by Type (2015-2020) 1.4.1 North America Trivalent Flu Vaccine Sales Breakdown by Type (2015-2026) 1.4.2 Europe Trivalent Flu Vaccine Sales Breakdown by Type (2015-2026) 1.4.3 Asia-Pacific Trivalent Flu Vaccine Sales Breakdown by Type (2015-2026) 1.4.4 Latin America Trivalent Flu Vaccine Sales Breakdown by Type (2015-2026) 1.4.5 Middle East and Africa Trivalent Flu Vaccine Sales Breakdown by Type (2015-2026) 2 Global Trivalent Flu Vaccine Market Competition by Company 2.1 Global Top Players by Trivalent Flu Vaccine Sales (2015-2020) 2.2 Global Top Players by Trivalent Flu Vaccine Revenue (2015-2020) 2.3 Global Top Players Trivalent Flu Vaccine Average Selling Price (ASP) (2015-2020) 2.4 Global Top Manufacturers Trivalent Flu Vaccine Manufacturing Base Distribution, Sales Area, Product Type 2.5 Trivalent Flu Vaccine Market Competitive Situation and Trends 2.5.1 Trivalent Flu Vaccine Market Concentration Rate (2015-2020) 2.5.2 Global 5 and 10 Largest Manufacturers by Trivalent Flu Vaccine Sales and Revenue in 2019 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Trivalent Flu Vaccine as of 2019) 2.7 Date of Key Manufacturers Enter into Trivalent Flu Vaccine Market 2.8 Key Manufacturers Trivalent Flu Vaccine Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Global Trivalent Flu Vaccine Status and Outlook by Region (2015-2026) 3.1 Global Trivalent Flu Vaccine Market Size and CAGR by Region: 2015 VS 2020 VS 2026 3.2 Global Trivalent Flu Vaccine Market Size Market Share by Region (2015-2020) 3.2.1 Global Trivalent Flu Vaccine Sales Market Share by Region (2015-2020) 3.2.2 Global Trivalent Flu Vaccine Revenue Market Share by Region (2015-2020) 3.2.3 Global Trivalent Flu Vaccine Sales, Revenue, Price and Gross Margin (2015-2020) 3.3 Global Trivalent Flu Vaccine Market Size Market Share by Region (2021-2026) 3.3.1 Global Trivalent Flu Vaccine Sales Market Share by Region (2021-2026) 3.3.2 Global Trivalent Flu Vaccine Revenue Market Share by Region (2021-2026) 3.3.3 Global Trivalent Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) 3.4 North America Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 3.4.1 North America Trivalent Flu Vaccine Revenue YoY Growth (2015-2026) 3.4.2 North America Trivalent Flu Vaccine Sales YoY Growth (2015-2026) 3.5 Asia-Pacific Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 3.5.1 Asia-Pacific Trivalent Flu Vaccine Revenue YoY Growth (2015-2026) 3.5.2 Asia-Pacific Trivalent Flu Vaccine Sales YoY Growth (2015-2026) 3.6 Europe Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 3.6.1 Europe Trivalent Flu Vaccine Revenue YoY Growth (2015-2026) 3.6.2 Europe Trivalent Flu Vaccine Sales YoY Growth (2015-2026) 3.7 Latin America Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 3.7.1 Latin America Trivalent Flu Vaccine Revenue YoY Growth (2015-2026) 3.7.2 Latin America Trivalent Flu Vaccine Sales YoY Growth (2015-2026) 3.8 Middle East and Africa Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 3.8.1 Middle East and Africa Trivalent Flu Vaccine Revenue YoY Growth (2015-2026) 3.8.2 Middle East and Africa Trivalent Flu Vaccine Sales YoY Growth (2015-2026) 4 Global Trivalent Flu Vaccine by Application 4.1 Trivalent Flu Vaccine Segment by Application 4.1.1 Hospital 4.1.2 Clinic 4.1.3 Public Health Agency 4.1.4 Other 4.2 Global Trivalent Flu Vaccine Sales by Application: 2015 VS 2020 VS 2026 4.3 Global Trivalent Flu Vaccine Historic Sales by Application (2015-2020) 4.4 Global Trivalent Flu Vaccine Forecasted Sales by Application (2021-2026) 4.5 Key Regions Trivalent Flu Vaccine Market Size by Application 4.5.1 North America Trivalent Flu Vaccine by Application 4.5.2 Europe Trivalent Flu Vaccine by Application 4.5.3 Asia-Pacific Trivalent Flu Vaccine by Application 4.5.4 Latin America Trivalent Flu Vaccine by Application 4.5.5 Middle East and Africa Trivalent Flu Vaccine by Application 5 North America Trivalent Flu Vaccine Market Size by Country (2015-2026) 5.1 North America Market Size Market Share by Country (2015-2020) 5.1.1 North America Trivalent Flu Vaccine Sales Market Share by Country (2015-2020) 5.1.2 North America Trivalent Flu Vaccine Revenue Market Share by Country (2015-2020) 5.2 North America Market Size Market Share by Country (2021-2026) 5.2.1 North America Trivalent Flu Vaccine Sales Market Share by Country (2021-2026) 5.2.2 North America Trivalent Flu Vaccine Revenue Market Share by Country (2021-2026) 5.3 North America Market Size YoY Growth by Country 5.3.1 U.S. Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 5.3.2 Canada Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 6 Europe Trivalent Flu Vaccine Market Size by Country (2015-2026) 6.1 Europe Market Size Market Share by Country (2015-2020) 6.1.1 Europe Trivalent Flu Vaccine Sales Market Share by Country (2015-2020) 6.1.2 Europe Trivalent Flu Vaccine Revenue Market Share by Country (2015-2020) 6.2 Europe Market Size Market Share by Country (2021-2026) 6.2.1 Europe Trivalent Flu Vaccine Sales Market Share by Country (2021-2026) 6.2.2 Europe Trivalent Flu Vaccine Revenue Market Share by Country (2021-2026) 6.3 Europe Market Size YoY Growth by Country 6.3.1 Germany Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 6.3.2 France Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 6.3.3 U.K. Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 6.3.4 Italy Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 6.3.5 Russia Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 7 Asia-Pacific Trivalent Flu Vaccine Market Size by Country (2015-2026) 7.1 Asia-Pacific Market Size Market Share by Country (2015-2020) 7.1.1 Asia-Pacific Trivalent Flu Vaccine Sales Market Share by Country (2015-2020) 7.1.2 Asia-Pacific Trivalent Flu Vaccine Revenue Market Share by Country (2015-2020) 7.2 Asia-Pacific Market Size Market Share by Country (2021-2026) 7.2.1 Asia-Pacific Trivalent Flu Vaccine Sales Market Share by Country (2021-2026) 7.2.2 Asia-Pacific Trivalent Flu Vaccine Revenue Market Share by Country (2021-2026) 7.3 Asia-Pacific Market Size YoY Growth by Country 7.3.1 China Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 7.3.2 Japan Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 7.3.3 South Korea Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 7.3.4 India Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 7.3.5 Australia Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 7.3.6 Taiwan Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 7.3.7 Indonesia Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 7.3.8 Thailand Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 7.3.9 Malaysia Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 7.3.10 Philippines Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 7.3.11 Vietnam Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 8 Latin America Trivalent Flu Vaccine Market Size by Country (2015-2026) 8.1 Latin America Market Size Market Share by Country (2015-2020) 8.1.1 Latin America Trivalent Flu Vaccine Sales Market Share by Country (2015-2020) 8.1.2 Latin America Trivalent Flu Vaccine Revenue Market Share by Country (2015-2020) 8.2 Latin America Market Size Market Share by Country (2021-2026) 8.2.1 Latin America Trivalent Flu Vaccine Sales Market Share by Country (2021-2026) 8.2.2 Latin America Trivalent Flu Vaccine Revenue Market Share by Country (2021-2026) 8.3 Latin America Market Size YoY Growth by Country 8.3.1 Mexico Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 8.3.2 Brazil Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 8.3.3 Argentina Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 9 Middle East and Africa Trivalent Flu Vaccine Market Size by Country (2015-2026) 9.1 Middle East and Africa Market Size Market Share by Country (2015-2020) 9.1.1 Middle East and Africa Trivalent Flu Vaccine Sales Market Share by Country (2015-2020) 9.1.2 Middle East and Africa Trivalent Flu Vaccine Revenue Market Share by Country (2015-2020) 9.2 Middle East and Africa Market Size Market Share by Country (2021-2026) 9.2.1 Middle East and Africa Trivalent Flu Vaccine Sales Market Share by Country (2021-2026) 9.2.2 Middle East and Africa Trivalent Flu Vaccine Revenue Market Share by Country (2021-2026) 9.3 Middle East and Africa Market Size YoY Growth by Country 9.3.1 Turkey Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 9.3.2 Saudi Arabia Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 9.3.3 U.A.E Trivalent Flu Vaccine Market Size YoY Growth (2015-2026) 10 Company Profiles and Key Figures in Trivalent Flu Vaccine Business 10.1 Sanofi Pasteur 10.1.1 Sanofi Pasteur Corporation Information 10.1.2 Sanofi Pasteur Description, Business Overview and Total Revenue 10.1.3 Sanofi Pasteur Trivalent Flu Vaccine Sales, Revenue and Gross Margin (2015-2020) 10.1.4 Sanofi Pasteur Trivalent Flu Vaccine Products Offered 10.1.5 Sanofi Pasteur Recent Development 10.2 AstraZeneca 10.2.1 AstraZeneca Corporation Information 10.2.2 AstraZeneca Description, Business Overview and Total Revenue 10.2.3 AstraZeneca Trivalent Flu Vaccine Sales, Revenue and Gross Margin (2015-2020) 10.2.4 Sanofi Pasteur Trivalent Flu Vaccine Products Offered 10.2.5 AstraZeneca Recent Development 10.3 CSL 10.3.1 CSL Corporation Information 10.3.2 CSL Description, Business Overview and Total Revenue 10.3.3 CSL Trivalent Flu Vaccine Sales, Revenue and Gross Margin (2015-2020) 10.3.4 CSL Trivalent Flu Vaccine Products Offered 10.3.5 CSL Recent Development 10.4 Abbott 10.4.1 Abbott Corporation Information 10.4.2 Abbott Description, Business Overview and Total Revenue 10.4.3 Abbott Trivalent Flu Vaccine Sales, Revenue and Gross Margin (2015-2020) 10.4.4 Abbott Trivalent Flu Vaccine Products Offered 10.4.5 Abbott Recent Development 10.5 GlaxoSmithKline 10.5.1 GlaxoSmithKline Corporation Information 10.5.2 GlaxoSmithKline Description, Business Overview and Total Revenue 10.5.3 GlaxoSmithKline Trivalent Flu Vaccine Sales, Revenue and Gross Margin (2015-2020) 10.5.4 GlaxoSmithKline Trivalent Flu Vaccine Products Offered 10.5.5 GlaxoSmithKline Recent Development 10.6 Serum Institute of India 10.6.1 Serum Institute of India Corporation Information 10.6.2 Serum Institute of India Description, Business Overview and Total Revenue 10.6.3 Serum Institute of India Trivalent Flu Vaccine Sales, Revenue and Gross Margin (2015-2020) 10.6.4 Serum Institute of India Trivalent Flu Vaccine Products Offered 10.6.5 Serum Institute of India Recent Development ... 11 Trivalent Flu Vaccine Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Trivalent Flu Vaccine Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Trivalent Flu Vaccine Industrial Chain Analysis 11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Porter’s Five Forces Analysis 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Distributors 12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Author Details 14.4 Disclaimer

List of Tables Table 1. Major Company of Intramuscular Injection Table 2. Major Company of Nasal Spray Table 3. Major Players of Intradermal Shot Table 4. Global Trivalent Flu Vaccine Market Size Growth Potential by Type: CAGR (2020-2026) (US$ Million) Table 5. Global Trivalent Flu Vaccine Sales (K Doses) by Type (2015-2020) (K Doses) Table 6. Global Trivalent Flu Vaccine Sales Share by Type (2015-2020) Table 7. Global Trivalent Flu Vaccine Revenue (Million USD) by Type (2015-2020) Table 8. Global Trivalent Flu Vaccine Revenue Share by Type (2015-2020) Table 9. Global Trivalent Flu Vaccine Average Selling Price (ASP) (USD/Dose) by Type (2015-2020) Table 10. Global Trivalent Flu Vaccine Sales by Type (2021-2026) (K Doses) Table 11. Global Trivalent Flu Vaccine Sales Share by Type (2021-2026) Table 12. Global Trivalent Flu Vaccine Revenue (US$ Million) by Type (2021-2026) Table 13. Global Trivalent Flu Vaccine Revenue Share by Type (2021-2026) Table 14. Global Trivalent Flu Vaccine Average Selling Price (ASP) (USD/Dose) by Type (2021-2026) Table 15. North America Trivalent Flu Vaccine Sales (USD/Dose) by Type (2015-2020) Table 16. Europe Trivalent Flu Vaccine Sales (USD/Dose) by Type (2015-2020) Table 17. Asia-Pacific Trivalent Flu Vaccine Sales (USD/Dose) by Type (2015-2020) Table 18. Latin America Trivalent Flu Vaccine Sales (USD/Dose) by Type (2015-2020) Table 19. Middle East and Africa Trivalent Flu Vaccine Sales (USD/Dose) by Type (2015-2020) Table 20. Global Trivalent Flu Vaccine Sales (K Doses) by Company (2015-2020) Table 21. Global Trivalent Flu Vaccine Sales Share by Company (2015-2020) Table 22. Global Trivalent Flu Vaccine Revenue (Million US$) by Company (2015-2020) Table 23. Global Trivalent Flu Vaccine Revenue Share by Company (2015-2020) Table 24. Global Market Trivalent Flu Vaccine Average Selling Price (USD/Dose) by Company (2015-2020) Table 25. Global Trivalent Flu Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area Table 26. Global Trivalent Flu Vaccine Top Manufacturers Product Category Table 27. Global Trivalent Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Trivalent Flu Vaccine as of 2019 Table 29. Date of Key Manufacturers Enter into Trivalent Flu Vaccine Market Table 30. Key Manufacturers Trivalent Flu Vaccine Product Type Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Trivalent Flu Vaccine Market Size Comparison by Region (2015-2026) (US$ Million): 2015 VS 2020 VS 2026 Table 33. Global Trivalent Flu Vaccine Sales (K Doses) by Region (2015-2020) Table 34. Global Trivalent Flu Vaccine Sales Market Share by Region (2015-2020) Table 35. Global Trivalent Flu Vaccine Revenue (US$ Million) by Region (2015-2020) Table 36. Global Trivalent Flu Vaccine Revenue Market Share by Region (2015-2020) Table 37. Global Trivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 38. Global Trivalent Flu Vaccine Sales (K Doses) by Region (2021-2026) Table 39. Global Trivalent Flu Vaccine Sales Market Share by Region (2021-2026) Table 40. Global Trivalent Flu Vaccine Revenue (US$ Million) by Region (2021-2026) Table 41. Global Trivalent Flu Vaccine Revenue Market Share by Region (2021-2026) Table 42. Global Trivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 43. Global Trivalent Flu Vaccine Sales (K Doses) by Application: 2015 VS 2020 VS 2026 Table 44. Global Trivalent Flu Vaccine Sales (K Doses) by Application (2015-2020) Table 45. Global Trivalent Flu Vaccine Sales Share by Application (2015-2020) Table 46. Global Trivalent Flu Vaccine Sales (K Doses) by Application (2021-2026) Table 47. Global Trivalent Flu Vaccine Sales Share by Application (2021-2026) Table 48. North America Trivalent Flu Vaccine Sales (K Doses) by Application (2015-2020) Table 49. North America Sales Trivalent Flu Vaccine Market Share by Application (2015-2020) Table 50. Europe Trivalent Flu Vaccine Sales (K Doses) by Application (2015-2020) Table 51. Europe Sales Trivalent Flu Vaccine Market Share by Application In 2019 Table 52. Asia-Pacific Trivalent Flu Vaccine Sales (K Doses) by Application (2015-2020) Table 53. Asia-Pacific Sales Trivalent Flu Vaccine Market Share by Application In 2019 Table 54. Latin America Trivalent Flu Vaccine Sales (K Doses) by Application (2015-2020) Table 55. Latin America Sales Trivalent Flu Vaccine Market Share by Application In 2019 Table 56. Middle East and Africa Trivalent Flu Vaccine Sales (K Doses) by Application (2015-2020) Table 57. Middle East and Africa Trivalent Flu Vaccine Sales Share by Application (2015-2020) Table 58. North America Trivalent Flu Vaccine Sales (K Doses) by Country (2015-2020) Table 59. North America Trivalent Flu Vaccine Sales Market Share by Country (2015-2020) Table 60. North America Trivalent Flu Vaccine Revenue (US$ Million) by Country (2015-2020) Table 61. North America Trivalent Flu Vaccine Revenue Market Share by Country (2015-2020) Table 62. North America Trivalent Flu Vaccine Sales (K Doses) by Country (2021-2026) Table 63. North America Trivalent Flu Vaccine Sales Market Share by Country (2021-2026) Table 64. North America Trivalent Flu Vaccine Revenue (US$ Million) by Country (2021-2026) Table 65. North America Trivalent Flu Vaccine Revenue Market Share by Country (2021-2026) Table 66. Europe Trivalent Flu Vaccine Sales (K Doses) by Country (2015-2020) Table 67. Europe Trivalent Flu Vaccine Sales Market Share by Country (2015-2020) Table 68. Europe Trivalent Flu Vaccine Revenue (US$ Million) by Country (2015-2020) Table 69. Europe Trivalent Flu Vaccine Revenue Market Share by Country (2015-2020) Table 70. Europe Trivalent Flu Vaccine Sales (K Doses) by Country (2021-2026) Table 71. Europe Trivalent Flu Vaccine Sales Market Share by Country (2021-2026) Table 72. Europe Trivalent Flu Vaccine Revenue (US$ Million) by Country (2021-2026) Table 73. Europe Trivalent Flu Vaccine Revenue Market Share by Country (2021-2026) Table 74. Asia-Pacific Trivalent Flu Vaccine Sales (K Doses) by Region (2015-2020) Table 75. Asia-Pacific Trivalent Flu Vaccine Sales Market Share by Region (2015-2020) Table 76. Asia-Pacific Trivalent Flu Vaccine Revenue (US$ Million) by Region (2015-2020) Table 77. Asia-Pacific Trivalent Flu Vaccine Revenue Market Share by Region (2015-2020) Table 78. Asia-Pacific Trivalent Flu Vaccine Sales (K Doses) by Region (2021-2026) Table 79. Asia-Pacific Trivalent Flu Vaccine Sales Market Share by Region (2021-2026) Table 80. Asia-Pacific Trivalent Flu Vaccine Revenue (US$ Million) by Region (2021-2026) Table 81. Asia-Pacific Trivalent Flu Vaccine Revenue Market Share by Region (2021-2026) Table 82. Latin America Trivalent Flu Vaccine Sales (K Doses) by Country (2015-2020) Table 83. Latin America Trivalent Flu Vaccine Sales Market Share by Country (2015-2020) Table 84. Latin America Trivalent Flu Vaccine Revenue (US$ Million) by Country (2015-2020) Table 85. Latin America Trivalent Flu Vaccine Revenue Market Share by Country (2015-2020) Table 86. Latin America Trivalent Flu Vaccine Sales (K Doses) by Country (2021-2026) Table 87. Latin America Trivalent Flu Vaccine Sales Market Share by Country (2021-2026) Table 88. Latin America Trivalent Flu Vaccine Revenue (US$ Million) by Country (2021-2026) Table 89. Latin America Trivalent Flu Vaccine Revenue Market Share by Country (2021-2026) Table 90. Middle East and Africa Trivalent Flu Vaccine Sales (K Doses) by Country (2015-2020) Table 91. Middle East and Africa Trivalent Flu Vaccine Sales Market Share by Country (2015-2020) Table 92. Middle East and Africa Trivalent Flu Vaccine Revenue (US$ Million) by Country (2015-2020) Table 93. Middle East and Africa Trivalent Flu Vaccine Revenue Market Share by Country (2015-2020) Table 94. Middle East and Africa Trivalent Flu Vaccine Sales (K Doses) by Country (2021-2026) Table 95. Middle East and Africa Trivalent Flu Vaccine Sales Market Share by Country (2021-2026) Table 96. Middle East and Africa Trivalent Flu Vaccine Revenue (US$ Million) by Country (2021-2026) Table 97. Middle East and Africa Trivalent Flu Vaccine Revenue Market Share by Country (2021-2026) Table 98. Sanofi Pasteur Corporation Information Table 99. Sanofi Pasteur Description and Business Overview Table 100. Sanofi Pasteur Trivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 101. Sanofi Pasteur Trivalent Flu Vaccine Product Table 102. Sanofi Pasteur Recent Development Table 103. AstraZeneca Corporation Information Table 104. AstraZeneca Description and Business Overview Table 105. AstraZeneca Trivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 106. AstraZeneca Trivalent Flu Vaccine Product Table 107. AstraZeneca Recent Development Table 108. CSL Corporation Information Table 109. CSL Description and Business Overview Table 110. CSL Trivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 111. CSL Trivalent Flu Vaccine Product Table 112. CSL Recent Development Table 113. Abbott Corporation Information Table 114. Abbott Description and Business Overview Table 115. Abbott Trivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 116. Abbott Trivalent Flu Vaccine Product Table 117. Abbott Recent Development Table 118. GlaxoSmithKline Corporation Information Table 119. GlaxoSmithKline Description and Business Overview Table 120. GlaxoSmithKline Trivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 121. GlaxoSmithKline Trivalent Flu Vaccine Product Table 122. GlaxoSmithKline Recent Development Table 123. Serum Institute of India Corporation Information Table 124. Serum Institute of India Description and Business Overview Table 125. Serum Institute of India Trivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 126. Serum Institute of India Trivalent Flu Vaccine Product Table 127. Serum Institute of India Recent Development Table 128. Key Raw Materials Lists Table 129. Raw Materials Key Suppliers Lists Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 131. Key Challenges Table 132. Market Risks Table 133. Distributors List Table 134. Trivalent Flu Vaccine Downstream Customers Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Trivalent Flu Vaccine Product Picture Figure 2. Global Trivalent Flu Vaccine Revenue (Million USD) Status and Outlook (2015-2026) Figure 3. Global Trivalent Flu Vaccine Sales (K Doses) Status and Outlook (2015-2026) Figure 4. Product Picture of Intramuscular Injection Figure 5. Global Intramuscular Injection Sales (K Doses) and Growth Rate (2015-2020) Figure 6. Product Picture of Nasal Spray Figure 7. Global Nasal Spray Sales (K Doses) and Growth Rate (2015-2020) Figure 8. Product Picture of Intradermal Shot Figure 9. Global Intradermal Shot Sales (K Doses) and Growth Rate (2015-2020) Figure 10. Global Trivalent Flu Vaccine Revenue and Growth Rate by Type (US$ Million) Figure 11. Global Trivalent Flu Vaccine Sales Market Share by Type (2015-2020) Figure 12. Global Trivalent Flu Vaccine Sales Market Share by Type in 2019 Figure 13. Global Trivalent Flu Vaccine Revenue Share by Type (2015-2020) Figure 14. Global Trivalent Flu Vaccine Revenue Market Share by Type in 2019 Figure 15. Global Trivalent Flu Vaccine Sales Market Share by Type (2021-2026) Figure 16. Global Trivalent Flu Vaccine Sales Market Share by Type In 2019 Figure 17. Global Trivalent Flu Vaccine Revenue Share by Type (2021-2026) Figure 18. Global Trivalent Flu Vaccine Revenue Market Share by Type In 2019 Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Trivalent Flu Vaccine Sales in 2019 Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Trivalent Flu Vaccine Revenue in 2019 Figure 21. Trivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 22. North America Trivalent Flu Vaccine Revenue (US$ Million) and Growth Rate (2015-2026) Figure 23. North America Trivalent Flu Vaccine Sales YoY Growth (2015-2026) (K Doses) Figure 24. Asia-Pacific Trivalent Flu Vaccine Revenue (US$ Million) and Growth Rate (2015-2026) Figure 25. Asia-Pacific Trivalent Flu Vaccine Sales YoY Growth (2015-2026) (K Doses) Figure 26. Europe Trivalent Flu Vaccine Revenue (US$ Million) and Growth Rate (2015-2026) Figure 27. Europe Trivalent Flu Vaccine Sales YoY Growth (2015-2026) (K Doses) Figure 28. Latin America Trivalent Flu Vaccine Revenue (US$ Million) and Growth Rate (2015-2026) Figure 29. Latin America Trivalent Flu Vaccine Sales YoY Growth (2015-2026) (K Doses) Figure 30. Middle East and Africa Trivalent Flu Vaccine Revenue (US$ Million) and Growth Rate (2015-2026) Figure 31. Middle East and Africa Trivalent Flu Vaccine Sales YoY Growth (2015-2026) (K Doses) Figure 32. Hospital Examples Figure 33. Clinic Examples Figure 34. Public Health Agency Examples Figure 35. Other Examples Figure 36. U.S. Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 37. U.S. Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 38. Canada Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 39. Canada Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 40. Germany Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 41. Germany Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 42. France Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 43. France Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 44. U.K. Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 45. U.K. Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 46. Italy Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 47. Italy Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 48. Russia Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 49. Russia Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 50. China Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 51. China Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 52. Japan Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 53. Japan Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 54. South Korea Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 55. South Korea Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 56. India Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 57. India Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 58. Australia Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 59. Australia Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 60. Taiwan Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 61. Taiwan Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 62. Indonesia Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 63. Indonesia Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 64. Thailand Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 65. Thailand Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 66. Malaysia Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 67. Malaysia Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 68. Philippines Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 69. Philippines Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 70. Vietnam Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 71. Vietnam Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 72. Mexico Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 73. Mexico Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 74. Brazil Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 75. Brazil Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 76. Argentina Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 77. Argentina Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 78. Turkey Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 79. Turkey Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 80. Saudi Arabia Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 81. Saudi Arabia Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 82. U.A.E Trivalent Flu Vaccine Sales (K Doses) (2015-2026) Figure 83. U.A.E Trivalent Flu Vaccine Revenue (US$ Million) (2015-2026) Figure 84. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018 Figure 85. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 86. CSL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Serum Institute of India Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Key Raw Materials Price Figure 91. Trivalent Flu Vaccine Manufacturing Cost Structure Figure 92. Trivalent Flu Vaccine Industrial Chain Analysis Figure 93. Porter's Five Forces Analysis Figure 94. Channels of Distribution Figure 95. Distributors Profiles Figure 96. Bottom-up and Top-down Approaches for This Report Figure 97. Data Triangulation Figure 98. Key Executives Interviewed

Sanofi Pasteur AstraZeneca CSL Abbott GlaxoSmithKline Serum Institute of India